Greek industry seeks justice after government pricing blunders
This article was originally published in Scrip
Executive Summary
Greece's national pharma association, SFEE, has taken legal action to the highest authority in Greece against a government which has persistently undermined the industry. One particularly notable violation is that despite Greece's very low drug prices, at least 270 have been wrongly listed as lower than they should be for over a year, and the government has made no move to correct its mistakes.